2020-06-17
The "Hainan Free Trade Port Boao Lecheng International Medical Tourism Pilot Zone Regulations" were promulgated and came into effect on June 16, 2020. The regulations stipulate that medical institutions within the pilot zone may conduct research and facilitate the clinical application of cutting-edge technologies such as stem cell therapy, immune cell therapy, monoclonal antibody drugs, gene therapy, and tissue engineering.
+2020-06-15
Stem Cells: A New Tool to Conquer Aplastic Anemia
Did you know? Every year, June 14 is celebrated as World Blood Donor Day. The date was chosen because it marks the birthday of Karl Landsteiner, the Nobel Prize-winning scientist who discovered the ABO blood group system. At the heart of World Blood Donor Day is recognition of the life-saving gift donated by voluntary, unpaid blood donors. In 2020, the campaign theme was "Safe Blood Saves Lives."
+2020-06-12
In the early hours of June 11, Beijing time, several leading international media outlets jointly reported that "King of Motorsports" Schumacher is about to undergo a groundbreaking new surgery— a stem-cell transplant aimed at rebuilding his nervous system. However, even medical experts currently regarded as the best in the world find it extremely challenging to predict his recovery prospects.
+2020-06-08
National Eye Care Day: Spotlight on Stem Cell Therapy for Retinal Macular Degeneration
June 6, 2020, marked the 25th National Eye Care Day, with this year's theme being "Vision 2020: Prioritizing Universal Eye Health."
+2020-06-04
Jiuzhitang Maker hosts the "Beautiful Moments, Captured by Technology" photography contest
To advance the company’s corporate culture and enrich employees' leisure activities, Jiuzhitang Maker hosted a photography competition on May 20, 2020, themed "Beautiful Moments Captured by Technology."
+2020-05-28
In the process of diagnosing and treating COVID-19, a new trend has emerged with the full-scale launch of precision medicine. Emerging cell-based therapies, such as those utilizing stem cells, are forging innovative pathways and offering fresh approaches and models for the 2019-nCoV COVID-19 treatment guidelines. In response, Li Zhenguo, a deputy to the National People's Congress and Chairman of Jiuzhitang Co., Ltd., once again recommends promoting the integration of traditional medicine with precision medicine to enhance capabilities in treating critical illnesses.
+2020-05-28
Currently, the inheritance, innovation, and development of Traditional Chinese Medicine (TCM) have been elevated to a national strategy. Particularly during the recent fight against the pandemic, as evidenced by the multiple versions of clinical treatment guidelines issued by the state, TCM and its herbal remedies have demonstrated remarkable effectiveness in boosting the body's immune system, alleviating fever symptoms, controlling disease progression, and reducing complications—thus playing a positive role in the prevention and treatment of COVID-19. In light of this, Li Zhenguo, a National People's Congress delegate and Chairman of Jiuzhitang Co., Ltd., has put forward a proposal at this year's Two Sessions: to comprehensively revitalize the TCM sector!
+2020-05-21
According to Representative Li Zhenguo, traditional medicine and precision medicine share common ground—after all, the core principles of TCM, such as "treating the same disease with different methods," "treating different diseases with the same method," and "diagnosing and treating based on syndrome differentiation," essentially embody the essence of precision medicine. He suggests that the nation should encourage traditional medicine and precision medicine to leverage their respective strengths, fostering a dynamic synergy between the two fields. Additionally, he urges medical institutions to embrace new technologies and innovative models, enabling the integrated application of traditional and precision medicine—and ultimately enhancing China's capacity to tackle critical illnesses.
+2020-05-19
On May 16, during the "Beijing Daxing District Key Industrial Parks Cloud Promotion Event" hosted by the Daxing Industry Promotion Association, the detailed plan for the Daxing Biomedical Base was unveiled for the first time. Notably, Jiuzhitang Maker has already been included in the Daxing government's development plans. The plan not only outlines the northward and southward expansion of the industrial zone, along with coordinated growth initiatives linking it to Daxing's western area, but also introduces groundbreaking updates such as the southern extension of Line 9 and the proposed site selection for Capital Medical University.
+